- Home
- INBK vs VNDA Comparison
INBK vs VNDA Comparison
Compare INBK & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBK
- VNDA
- Stock Information
- Founded
- INBK 1999
- VNDA 2002
- Country
- INBK United States
- VNDA United States
- Employees
- INBK N/A
- VNDA N/A
- Industry
- INBK Major Banks
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- INBK Finance
- VNDA Health Care
- Exchange
- INBK Nasdaq
- VNDA Nasdaq
- Market Cap
- INBK 289.7M
- VNDA 257.8M
- IPO Year
- INBK N/A
- VNDA 2006
- Fundamental
- Price
- INBK $30.39
- VNDA $4.43
- Analyst Decision
- INBK Buy
- VNDA Strong Buy
- Analyst Count
- INBK 3
- VNDA 2
- Target Price
- INBK $41.00
- VNDA $16.50
- AVG Volume (30 Days)
- INBK 33.3K
- VNDA 649.7K
- Earning Date
- INBK 01-22-2025
- VNDA 02-13-2025
- Dividend Yield
- INBK 0.79%
- VNDA N/A
- EPS Growth
- INBK 203.16
- VNDA N/A
- EPS
- INBK 2.88
- VNDA N/A
- Revenue
- INBK $117,652,000.00
- VNDA $198,772,000.00
- Revenue This Year
- INBK N/A
- VNDA $16.07
- Revenue Next Year
- INBK $19.61
- VNDA $24.42
- P/E Ratio
- INBK $10.55
- VNDA N/A
- Revenue Growth
- INBK 39.44
- VNDA 3.18
- 52 Week Low
- INBK $24.18
- VNDA $3.71
- 52 Week High
- INBK $43.26
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- INBK 31.34
- VNDA 44.53
- Support Level
- INBK $31.08
- VNDA $4.34
- Resistance Level
- INBK $33.72
- VNDA $4.65
- Average True Range (ATR)
- INBK 1.21
- VNDA 0.21
- MACD
- INBK -0.10
- VNDA -0.01
- Stochastic Oscillator
- INBK 0.00
- VNDA 36.51
About INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking/treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.